Lease Agreement for the Bio Rad D10 Hemoglobin A1C Analyzer for The Regional Clinical Laboratory at Austin State Hospital (RCLA)

The Health and Human Services Commission of Texas is soliciting competitive bids for a lease agreement to acquire the Bio Rad D10 Hemoglobin A1C analyzer, along with associated service and consumables, for use at the Regional Clinical Laboratory at Austin State Hospital. The solicitation, identified as HHS0017429, was posted on the Texas SmartBuy portal on July 15, 2026, with a response deadline of August 5, 2026, at 10:30 AM Central Time. All questions and clarifications must be submitted by July 24, 2026, and any resulting addenda will be posted by July 28, 2026. The anticipated contract start date is September 1, 2026, and the equipment will be deployed at a state-operated facility in Texas. This solicitation is open to all eligible vendors without a specified set-aside classification and is managed under the state’s procurement process for SLED agencies. Vanessa Cantu serves as the primary point of contact for inquiries, reachable via email at [email hidden] or by phone at [phone hidden]. The contract will cover the lease of the analyzer, ongoing technical service, and a continuous supply of necessary consumables to ensure uninterrupted operation of the device. All responses must be submitted through the official esbd portal linked in the solicitation. The acquisition aims to support the laboratory’s diagnostic capabilities for hemoglobin A1C testing, critical for patient care and compliance with clinical standards. Bidders are expected to provide comprehensive pricing, service level agreements, and delivery timelines aligned with the contract’s start date and operational needs.